HemaSphere
(Jun 2022)
P1489: MANAGEMENT OF SICKLE CELL DISEASE WITH HYDROXYUREA: A SYSTEMATIC REVIEW FROM LOW- AND MIDDLE-INCOME COUNTRIES
- V. Paintsil,
- K. Marfo,
- F. Adisa,
- S. Khan,
- L. M. Tshilolo
Affiliations
- V. Paintsil
- 1 Kwame Nkrumah University of Science and Technology/Komfo Anokye Teaching Hospital, Kumasi, Ghana
- K. Marfo
- 2 Novartis Pharma AG, Switzerland, Basel, Switzerland
- F. Adisa
- 3 Novartis Pharmaceuticals Inc., United states, Cambridge, United States of America
- S. Khan
- 4 Novartis Healthcare Pvt Ltd, Hyderabad, India
- L. M. Tshilolo
- 5 Centre Hospitalier Mère-Enfant, CEFA/Monkole, Kinshasa, Democratic Republic of the Congo, Kinshasa, Congo, The Democratic Republic of the
- DOI
-
https://doi.org/10.1097/01.HS9.0000848812.59349.97
- Journal volume & issue
-
Vol. 6
pp.
1371
– 1372
WeChat QR code